Delivery Order SPE2DB22D2206-SPE2DB25FHJ00
Award Date
6/9/25
Potential Completion Date
7/1/25
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,797.84 firm fixed price delivery order is for IBRANCE 75 MG CAPSULE 21S, a medication, with a period of performance through May 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a $16,247.92 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IBRANCE 75 MG CAPSULE 21S, with a period of performance ending on June 12, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $16,236.16 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of IBRANCE 125MG CAP 21S, a specialty medication. The contract has an ultimate completion date of May 2, 2025 and was awarded on April 11, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which...
This is a delivery order issued under a $999,999,999 Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IBRANCE 125 MG CAPSULE 21S. The order, with a ceiling value of $7,792.08, is a firm fixed-price contract that will run through November 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves as a primary vehicle for...
This is a $8,122.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 100 MG TABLET 7S, a prescription medication, with a period of performance ending on July 8, 2025. The contract is not set aside and is awarded as part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a $15,595.70 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to the AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the delivery of the pharmaceutical product IBRANCE 75 MG CAPSULE 21S. This contract is not set aside. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on supporting military treatment facilities, veterans' hospitals, and other...
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide IBRANCE 75 MG CAPSULE 21S medication. The order has a ceiling value of $15,595.70 and a period of performance through April 17, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of pharmaceuticals, specifically the drug IBRANCE 100 MG TABLET 7S, with a ceiling value of $7,796.30 and an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to...
This is a $48,734.88 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of IBRANCE 100 MG CAPSULE 21S, a prescription medication, with a period of performance ending on July 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...